Table 1.
Baseline clinical characteristics and medication of RA patients ( ± SEM or n%).
| Baseline value | |
|---|---|
| Age, year | 50.29 ± 0.93 |
| Male/female | 40/128 |
| Disease duration, years | 9.62 ± 2.23 |
| DAS28 | 4.41 ± 1.39 |
| ESR, mm/h | 55.69 ± 3.68 |
| CRP, μg/ml | 33.84 ± 3.50 |
| RF, IU/ml | 79.01 ± 7.39 |
| Anti-CCP Ab, U/ml | 173.80 ± 18.35 |
| Current NSAID users | 4 (2.38) |
| Current DMARD users | 21 (12.50) |
| Current steroid users | 2 (11.90) |
| Two-type drug users | 67 (39.88) |
| Three-type drug users | 15 (8.93) |
| No systemic therapy patients | 59 (35.11) |
ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; DAS: disease activity score; RF: rheumatoid factor; CCP: cyclic citrullinated peptide; NSAIDs: nonsteroidal anti-inflammatory drugs; DMARDs: disease-modifying antirheumatic drugs.